Drugs / Fluorothymidine (FLT)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03546556 | Jan 2017 → Mar 2020 | graft versus host disease | UNC Lineberger Comprehensive Cancer Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorothymidine (FLT) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03546556 ↗ |
| Modality | Diagnostic / imaging agent | “FLT-PET-MRI imaging” NCT03546556 ↗ |